SG Americas Securities’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.87M Buy
38,482
+9,141
+31% +$445K 0.01% 724
2025
Q1
$998K Buy
29,341
+8,240
+39% +$280K ﹤0.01% 1050
2024
Q4
$831K Sell
21,101
-4,610
-18% -$182K ﹤0.01% 824
2024
Q3
$1.21M Sell
25,711
-468
-2% -$22K ﹤0.01% 811
2024
Q2
$1.41M Sell
26,179
-12,627
-33% -$682K 0.01% 1042
2024
Q1
$2.65M Sell
38,806
-9,207
-19% -$628K 0.01% 722
2023
Q4
$3.01M Buy
48,013
+24,850
+107% +$1.56M 0.03% 445
2023
Q3
$1.05M Sell
23,163
-3,818
-14% -$173K 0.01% 1133
2023
Q2
$1.52M Buy
26,981
+521
+2% +$29.3K 0.01% 786
2023
Q1
$1.2M Sell
26,460
-873
-3% -$39.5K 0.01% 927
2022
Q4
$1.11M Buy
27,333
+14,493
+113% +$589K 0.01% 781
2022
Q3
$839K Sell
12,840
-50,372
-80% -$3.29M 0.01% 979
2022
Q2
$3.84M Buy
63,212
+58,765
+1,321% +$3.57M 0.04% 326
2022
Q1
$279K Sell
4,447
-18,703
-81% -$1.17M ﹤0.01% 1994
2021
Q4
$1.75M Sell
23,150
-48,806
-68% -$3.7M 0.01% 1090
2021
Q3
$8.05M Buy
71,956
+11,234
+19% +$1.26M 0.04% 291
2021
Q2
$9.83M Buy
60,722
+1,012
+2% +$164K 0.05% 319
2021
Q1
$7.28M Buy
59,710
+54,346
+1,013% +$6.62M 0.04% 333
2020
Q4
$821K Sell
5,364
-1,543
-22% -$236K ﹤0.01% 1446
2020
Q3
$578K Sell
6,907
-1,464
-17% -$123K ﹤0.01% 1280
2020
Q2
$615K Buy
+8,371
New +$615K 0.01% 1609
2020
Q1
Sell
-6,585
Closed -$401K 2877
2019
Q4
$401K Sell
6,585
-11,919
-64% -$726K ﹤0.01% 1685
2019
Q3
$758K Buy
+18,504
New +$758K 0.01% 1388